Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | 1 | Unknown | — |
The patient got the first dose of RabAvert last year on 03NOV2023 and never came for the second dose; Case reference number US-BN-2024-002673 is a spontaneous case initially received from pharmacist via Med Communications (reference number USBAV24-2786) on 22-Oct-2024 and concerns a male patient of unknown age. The patient's medical history and concomitant medication details were not provided. On 03-Nov-2023, the patient was vaccinated with the first dose of RabAvert (batch number: unknown), at an unknown dose, route, or site of administration, for pre-exposure treatment. As reported, the patient never came for the second dose of RabAvert (explicitly codes as 'incomplete course of vaccination'). At the time of the initial report, it was unknown if the patient experienced any adverse event due to RabAvert vaccine. No further information was provided.; Reporter's Comments: A male patient received the first dose of RabAvert for pre-exposure prophylaxis, but never returned for a second dose, which is considered incomplete course of vaccination. This is a listed event as per company convention. No associated adverse events were reported. Medical history was not reported. Incomplete course of vaccination is not related to RabAvert, but to human error. The case is non-serious.; Sender's Comments: A male patient received the first dose of RabAvert for pre-exposure prophylaxis, but never returned for a second dose, which is considered incomplete course of vaccination. This is a listed event as per company convention. No associated adverse events were reported. Medical history was not reported. Incomplete course of vaccination is not related to RabAvert, but to human error. The case is non-serious.
Comments: None